Enhanced aseptic sampling system

NovAseptic has recently added a new line of products to their NovaSeptum sampling portfolio to provide additional security and flexibility to an already unique product range

NovAseptic has recently added a new line of products to their NovaSeptum sampling portfolio to provide additional security and flexibility to an already unique product range.

The aseptic disposable sampling system has been validated for use by many of the world's leading pharmaceutical and biotechnology companies.

The NovaSeptum not only eliminates false positives associated with aseptic liquid sampling, but also removes the requirement to clean and steam in place between samples.

Recent product enhancements have further increased the demand for the NovaSeptum.

First is the introduction of an autoclavable range for applications where mobile production vessels are autoclaved whilst fully assembled.

A new 2mm sample needle designed for cell culture applications and suspensions.

The introduction of a three piece sample retrieval assembly which provides complete flexibility and security for the person responsible for sample analysis.

New production techniques has resulted in a reduction in the guaranteed endotoxin level from less than 20EU/device to less than 2.15 EU/device on all NovaSeptum products.

For those currently using the NovaSeptum, the following inherent advantages are being experienced.

The totally enclosed system ensures that false positives are eliminated.

The pre-irradiated unit negates the need to sterilise between each sample Sampling time is dramatically reduced.

A representative sample is provided every time.

Operator safety is guaranteed.

Flexible hardware configurations ensure that samples can be taken from anywhere within the process system.

Comprehensive documentation packages reduce validation time.

The same system can also be implemented for aseptic transfer of liquids into the process system.

Back to top